Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Network Type I Analysis

Type 1 network in which we propagated the absolute log regulation ratio abs(log(r/g)). We used the filtered lowest boundary of the confidence interval for the microarray measurement based and used the high confidence interaction map. Because type-I networks tend to favour highly connected proteins we tested a normalisation scheme in which we would run the network once with real values (the measured column) and once with simulated values where each measured point is set to 1 instead of the actual signal (the expected column). Afterwards we divided the measured value by the expected value. This normalisation scheme works to a certain extend but will lead to a variance that is directly related to the connectivity of each protein. In the end we dropped the use of Type-I networks due to the many technical problems they pose.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description measured expected final Hugo
Results: HTML CSV LaTeX
Showing element 2501 to 2550 of 3206 in total

\def\wcA{0.14285714285714\textwidth}
\def\wcB{0.14285714285714\textwidth}
\def\wcC{0.14285714285714\textwidth}
\def\wcD{0.14285714285714\textwidth}
\def\wcE{0.14285714285714\textwidth}
\def\wcF{0.14285714285714\textwidth}
\begin{longtable}{|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
measured\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
expected\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
final\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2501\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SH3-CONTAINING GRB2-LIKE PROTEIN 1 (SH3 DOMAIN PROTEIN 2B) (EXTRA ELEVEN-NINETEEN LEUKEMIA FUSION GENE) (EEN) (EEN FUSION PARTNER OF MLL). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.172401\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.800978\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.215238121\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SH3GL1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2502\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KERATIN ASSOCIATED PROTEIN 9-4; KERATIN ASSOCIATED PROTEIN 9.4. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1.02862\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
4.7857\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.214936164\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2503\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
JUNCTIONAL ADHESION MOLECULE 1 PRECURSOR (JAM) (PLATELET ADHESION MOLECULE 1) (PAM-1) (PLATELET F11 RECEPTOR). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.26445\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.23096\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.214832326\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
F11R\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2504\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ORNITHINE DECARBOXYLASE ANTIZYME INHIBITOR. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.174979\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.814661\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.214787501\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
AZIN1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2505\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ORNITHINE DECARBOXYLASE-LIKE PROTEIN (EC 4.1.1.17) (ODC-PARALOGUE) (ODC-P). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.177719\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.827431\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.214784073\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ADC\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2506\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"PLECKSTRIN HOMOLOGY DOMAIN CONTAINING, FAMILY C (WITH FERM DOMAIN) MEMBER 1; MITOGEN INDUCIBLE 2; KINDLIN 2. \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.0405241\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.188688\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.214767765\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
PLEKHC1\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
2507\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ALPHA-PARVIN (CALPONIN-LIKE INTEGRIN-LINKED KINASE BINDING PROTEIN) (CH-ILKBP). \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2508\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RAS SUPPRESSOR PROTEIN 1 (RSU-1) (RSP-1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.214312\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.997879\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.214767522\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
RSU1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2509\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
D(4) DOPAMINE RECEPTOR (D(2C) DOPAMINE RECEPTOR). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0585879\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.272797\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.214767391\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
DRD4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2510\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
AMINOADIPATE-SEMIALDEHYDE SYNTHASE; LYSINE-KETOGLUTARATE REDUCTASE /SACCHAROPINE DEHYDROGENASE; LYSINE-2-OXOGLUTARATE REDUCTASE; AMINOADIPIC SEMIALDEHYDE SYNTHASE. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0833117\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.387916\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.214767372\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
AASS\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2511\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0343037\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.159725\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.214767256\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
C20orf42\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2512\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
INTEGRIN-LINKED PROTEIN KINASE 1 (EC 2.7.1.-) (ILK-1) (59 KDA SERINE/THREONINE PROTEIN KINASE) (P59ILK). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.192216\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.894997\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.2147672\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ILK\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2513\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
PINCH PROTEIN (PARTICULARLY INTERESTING NEW CYS-HIS PROTEIN) (LIM AND SENESCENT CELL ANTIGEN-LIKE DOMAINS 1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.113204\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.527101\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.214767189\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
LIMS1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2514\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
LIM AND SENESCENT CELL ANTIGEN-LIKE DOMAINS 2; ILK-BINDING PROTEIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.117844\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.548706\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.214767107\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
LIMS2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2515\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ESPIN. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0601277\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.279967\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.214767098\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ESPNP\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2516\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
STAR-RELATED LIPID TRANSFER PROTEIN 5 (STARD5) (START DOMAIN- CONTAINING PROTEIN 5). \vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.0598238\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.278552\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.214767081\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
STARD5\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
2517\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
C11orf46\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
2518\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RAS-GTPASE-ACTIVATING PROTEIN BINDING PROTEIN 2 (GAP SH3-DOMAIN BINDING PROTEIN 2) (G3BP-2). \vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
G3BP2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2519\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
RAS-GTPASE-ACTIVATING PROTEIN BINDING PROTEIN 1 (GAP SH3-DOMAIN BINDING PROTEIN 1) (G3BP-1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0506049\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.235627\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.214766983\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
G3BP1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2520\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
CYTOCHROME P450 2D6 (EC 1.14.14.1) (CYPIID6) (P450-DB1) (DEBRISOQUINE 4-HYDROXYLASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0555486\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.258646\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.214766901\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
CYP2D6\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2521\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KERATIN ASSOCIATED PROTEIN 4-12; KERATIN ASSOCIATED PROTEIN 4.12. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.042399\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.19742\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.214765475\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2522\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0436957\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.203458\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.21476521\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2523\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
STAR-RELATED LIPID TRANSFER PROTEIN 4 (STARD4) (START DOMAIN- CONTAINING PROTEIN 4). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0433512\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.201854\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.214765127\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
STARD4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2524\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
STAR-RELATED LIPID TRANSFER PROTEIN 6 (STARD6) (START DOMAIN- CONTAINING PROTEIN 6). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.043878\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.204307\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.214765035\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
STARD6\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2525\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KERATIN ASSOCIATED PROTEIN 4.9 (FRAGMENT). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0383264\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.178458\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.214764258\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2526\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KERATIN ASSOCIATED PROTEIN 4-14; KERATIN ASSOCIATED PROTEIN 4.14. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0382656\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.178175\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.214764136\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2527\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KERATIN ASSOCIATED PROTEIN 4.4. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0320251\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.149118\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.214763476\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
KRTAP4-4\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2528\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KERATIN ASSOCIATED PROTEIN 4-2; KERATIN ASSOCIATED PROTEIN 4.2. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0314375\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.146383\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.21476196\vspace{3pt}}&\multirow{7}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}}\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2529\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KERATIN ASSOCIATED PROTEIN 4-10; KERATIN ASSOCIATED PROTEIN 4.10. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0280741\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.130722\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.214761861\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2530\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"KERATIN, ULTRA HIGH-SULFUR MATRIX PROTEIN A (UHS KERATIN A) (UHS KERA). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0250957\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.116854\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.214761155\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2531\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KERATIN ASSOCIATED PROTEIN 1-3; KERATIN ASSOCIATED PROTEIN 1.3. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0258656\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.120439\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.214760999\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2532\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KERATIN ASSOCIATED PROTEIN 1.5. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0249741\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.116288\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.214760766\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2533\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KERATIN ASSOCIATED PROTEIN 2-4; KERATIN ASSOCIATED PROTEIN 2.4. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0240826\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.112137\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.214760516\vspace{3pt}}&\\\cline{1-5}
\parbox{\wcA}{\vspace{3pt}\noindent
2534\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KERATIN ASSOCIATED PROTEIN 4.3 (FRAGMENT). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0260682\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.121383\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.214759892\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2535\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"KERATIN, ULTRA HIGH-SULFUR MATRIX PROTEIN B (UHS KERATIN B) (UHS KERB). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0249538\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.116194\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.214759798\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
KRTAP5-8\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2536\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ORNITHINE DECARBOXYLASE (EC 4.1.1.17) (ODC). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.220469\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
1.02669\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.214737652\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
ODC1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2537\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"[3-METHYL-2-OXOBUTANOATE DEHYDROGENASE [LIPOAMIDE]] KINASE, MITOCHONDRIAL PRECURSOR (EC 2.7.1.115) (BRANCHED-CHAIN ALPHA-KETOACID DEHYDROGENASE KINASE) (BCKDHKIN) (BCKD-KINASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1.13737\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5.29857\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.21465603\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
BCKDK\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2538\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DIPEPTIDYLPEPTIDASE 10; DIPEPTIDYL PEPTIDASE IV-RELATED PROTEIN 3. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.031831\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.148314\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.214618984\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
DPP10\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2539\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
DIPEPTIDYL AMINOPEPTIDASE-LIKE PROTEIN 6 (DIPEPTIDYLPEPTIDASE VI) (DIPEPTIDYLPEPTIDASE 6) (DIPEPTIDYL PEPTIDASE IV LIKE PROTEIN) (DIPEPTIDYL AMINOPEPTIDASE-RELATED PROTEIN) (DPPX). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0311751\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.145258\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.214618816\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
DPP6\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2540\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SEPRASE (EC 3.4.21.-) (FIBROBLAST ACTIVATION PROTEIN ALPHA) (INTEGRAL MEMBRANE SERINE PROTEASE) (170-KDA MELANOMA MEMBRANE-BOUND GELATINASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0377549\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.175918\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.214616469\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
FAP\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2541\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0217565\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.101375\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.214614057\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2542\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
SURFEIT LOCUS PROTEIN 1. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.12372\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.576477\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.214613939\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
SURF1\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2543\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0209707\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.0977138\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.214613494\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
FAM86C\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2544\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
COX15 HOMOLOG ISOFORM 2 PRECURSOR; CYTOCHROME C OXIDASE SUBUNIT 15; CYTOCHROME C OXIDASE ASSEMBLY PROTEIN. \vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
0.0273323\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
0.127356\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
0.214613367\vspace{3pt}}}&\parbox{\wcF}{\vspace{3pt}\noindent
COX15\vspace{3pt}}\\\cline{1-2}\cline{6-6}
\parbox{\wcA}{\vspace{3pt}\noindent
2545\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&&&&\parbox{\wcF}{\vspace{3pt}\noindent
FAM86B2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2546\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"CYTOCHROME C OXIDASE ASSEMBLY PROTEIN COX11, MITOCHONDRIAL PRECURSOR. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.124724\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.581157\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.214613263\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
COX11\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2547\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"PROTOHEME IX FARNESYLTRANSFERASE, MITOCHONDRIAL PRECURSOR (EC 2.5.1.-) (HEME O SYNTHASE). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.0819968\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
0.382068\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.214613106\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
COX10\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2548\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
KERATIN ASSOCIATED PROTEIN 9.2. \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
1.11949\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
5.2164\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.214609693\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
KRTAP9-8\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2549\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"[PYRUVATE DEHYDROGENASE [LIPOAMIDE]] KINASE ISOZYME 2, MITOCHONDRIAL PRECURSOR (EC 2.7.1.99) (PYRUVATE DEHYDROGENASE KINASE ISOFORM 2). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.845658\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3.9409\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.214584993\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PDK2\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2550\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
"[PYRUVATE DEHYDROGENASE [LIPOAMIDE]] KINASE ISOZYME 1, MITOCHONDRIAL PRECURSOR (EC 2.7.1.99) (PYRUVATE DEHYDROGENASE KINASE ISOFORM 1). \vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
0.844424\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
3.93515\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
0.214584959\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
PDK1\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the bloody hugo identifier as demanded by the BMC Bioinformatics idiots
- http://analysis.yellowcouch.org/